Annual Operating Expenses:
$168.44M+$14.30M(+9.28%)Summary
- As of today, AMPH annual total operating expenses is $168.44 million, with the most recent change of +$14.30 million (+9.28%) on December 31, 2024.
- During the last 3 years, AMPH annual operating expenses has risen by +$38.58 million (+29.71%).
- AMPH annual operating expenses is now at all-time high.
Performance
AMPH Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Expenses:
$69.70M+$29.38M(+72.86%)Summary
- As of today, AMPH quarterly total operating expenses is $69.70 million, with the most recent change of +$29.38 million (+72.86%) on September 30, 2025.
- Over the past year, AMPH quarterly operating expenses has increased by +$28.08 million (+67.49%).
- AMPH quarterly operating expenses is now at all-time high.
Performance
AMPH Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AMPH Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +9.3% | +67.5% |
| 3Y3 Years | +29.7% | +112.4% |
| 5Y5 Years | +27.6% | +129.3% |
AMPH Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +29.7% | at high | +126.3% |
| 5Y | 5-Year | at high | +29.7% | at high | +192.0% |
| All-Time | All-Time | at high | +173.5% | at high | +415.5% |
AMPH Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $69.70M(+72.9%) |
| Jun 2025 | - | $40.32M(-10.0%) |
| Mar 2025 | - | $44.78M(+17.2%) |
| Dec 2024 | $168.44M(+9.3%) | $38.22M(-8.1%) |
| Sep 2024 | - | $41.62M(+13.0%) |
| Jun 2024 | - | $36.83M(-6.2%) |
| Mar 2024 | - | $39.28M(-0.8%) |
| Dec 2023 | $154.13M(+9.0%) | $39.59M(+19.0%) |
| Sep 2023 | - | $33.27M(-0.5%) |
| Jun 2023 | - | $33.45M(-11.9%) |
| Mar 2023 | - | $37.97M(+23.3%) |
| Dec 2022 | $141.36M(+8.9%) | $30.80M(-6.1%) |
| Sep 2022 | - | $32.81M(-8.8%) |
| Jun 2022 | - | $35.98M(+13.9%) |
| Mar 2022 | - | $31.59M(+7.8%) |
| Dec 2021 | $129.85M(-1.9%) | $29.29M(+22.7%) |
| Sep 2021 | - | $23.87M(-29.5%) |
| Jun 2021 | - | $33.86M(+6.8%) |
| Mar 2021 | - | $31.70M(+1.6%) |
| Dec 2020 | $132.39M(+0.3%) | $31.19M(+2.6%) |
| Sep 2020 | - | $30.40M(-9.6%) |
| Jun 2020 | - | $33.64M(+24.6%) |
| Mar 2020 | - | $27.00M(-13.8%) |
| Dec 2019 | $131.96M(+14.1%) | $31.31M(+2.1%) |
| Sep 2019 | - | $30.68M(+4.8%) |
| Jun 2019 | - | $29.27M(-8.4%) |
| Mar 2019 | - | $31.95M(+0.3%) |
| Dec 2018 | $115.61M | $31.86M(+25.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $25.42M(-7.1%) |
| Jun 2018 | - | $27.38M(+8.6%) |
| Mar 2018 | - | $25.22M(+23.4%) |
| Dec 2017 | $94.42M(+6.3%) | $20.43M(-8.7%) |
| Sep 2017 | - | $22.37M(-4.6%) |
| Jun 2017 | - | $23.45M(+2.0%) |
| Mar 2017 | - | $22.99M(-2.7%) |
| Dec 2016 | $88.82M(+5.4%) | $23.64M(+14.5%) |
| Sep 2016 | - | $20.64M(+2.8%) |
| Jun 2016 | - | $20.09M(+5.7%) |
| Mar 2016 | - | $19.00M(+6.9%) |
| Dec 2015 | $84.25M(+21.7%) | $17.77M(-13.0%) |
| Sep 2015 | - | $20.43M(-9.2%) |
| Jun 2015 | - | $22.51M(+15.2%) |
| Mar 2015 | - | $19.53M(+3.3%) |
| Dec 2014 | $69.24M(-0.1%) | $18.91M(-3.5%) |
| Sep 2014 | - | $19.59M(+22.6%) |
| Jun 2014 | - | $15.98M(+18.2%) |
| Mar 2014 | - | $13.52M(-14.0%) |
| Dec 2013 | $69.34M(+10.4%) | $15.72M(-21.6%) |
| Sep 2013 | - | $20.05M(+29.3%) |
| Jun 2013 | - | $15.51M(-6.1%) |
| Mar 2013 | - | $16.51M(+4.5%) |
| Dec 2012 | $62.81M(+2.0%) | - |
| Dec 2012 | - | $15.80M(+3.8%) |
| Sep 2012 | - | $15.21M(-9.1%) |
| Jun 2012 | - | $16.73M(+11.0%) |
| Mar 2012 | - | $15.07M |
| Dec 2011 | $61.58M | - |
FAQ
- What is Amphastar Pharmaceuticals, Inc. annual total operating expenses?
- What is the all-time high annual operating expenses for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. annual operating expenses year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. quarterly total operating expenses?
- What is the all-time high quarterly operating expenses for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?
What is Amphastar Pharmaceuticals, Inc. annual total operating expenses?
The current annual operating expenses of AMPH is $168.44M
What is the all-time high annual operating expenses for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high annual total operating expenses is $168.44M
What is Amphastar Pharmaceuticals, Inc. annual operating expenses year-on-year change?
Over the past year, AMPH annual total operating expenses has changed by +$14.30M (+9.28%)
What is Amphastar Pharmaceuticals, Inc. quarterly total operating expenses?
The current quarterly operating expenses of AMPH is $69.70M
What is the all-time high quarterly operating expenses for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high quarterly total operating expenses is $69.70M
What is Amphastar Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?
Over the past year, AMPH quarterly total operating expenses has changed by +$28.08M (+67.49%)